Leadership Team

The Leadership Team at Cydan drives the strategic vision and operational execution of the company's orphan drug acceleration initiatives. Comprising experts in business development, preclinical research, and medical strategy, the team identifies promising therapeutic assets, oversees rigorous de-risking processes, and fosters partnerships to establish successful standalone companies focused on rare diseases. Their collective expertise ensures the effective translation of scientific innovation into viable treatment options.